Latest Developments in Global Suction And Aspiration Devices Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Suction And Aspiration Devices Market

  • Healthcare
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In June 2024, DelveInsight's report on the Thrombectomy Devices Market indicated that the market witnessed growth at a CAGR of ~5% by 2030. This growth was driven by the rise in lifestyle-related conditions such as obesity, diabetes, and aging, along with the increasing incidence of venous thromboembolism, cardiovascular diseases, and neurological disorders such as strokes
  • In April 2024, Flexicare (Group) Limited, a prominent designer and global provider of innovative medical devices, acquired Allied Healthcare Products. The acquisition aims to expand Flexicare’s product portfolio to include novel areas such as emergency products, medical gas systems, suction regulators and aspirators, transport ventilators, CO2 absorbents, and home healthcare products, using established brands such as Gomco, Lif-O-Gen, Chemetron, Timeter, Vacutron, Schuco, B&F Medical, Carbolime, and LithoLyme
  • In April 2024, Medical device giant Johnson & Johnson (J&J) launched two new products in Europe, the Ethizia haemostatic sealing patch and the Cereglide aspiration catheter. Ethizia, approved in November 2023, stopped bleeding in 80% of patients within 30 seconds, six times faster than the leading Fibrin sealing patch. This followed J&J's acquisition of GATT Technologies in 2022
  • In March 2023, Amsino International Inc. awarded a suction and fluid management product agreement to Premier Inc. The agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for suction and fluid management products
  • In April 2021, Market research firm GlobalData's report on Neurovascular Thrombectomy Devices showed that the U.S. thrombectomy device market was valued at approximately $265 million in 2020 and was expected to grow to $465 million by 2025. This growth was driven by an increase in thrombectomy procedures and the FDA approval of the adjustable stent retriever, TigerTriever, which offered greater control and reduced clot fragmentation risk.
  • In October 2020, Medela healthcare had launched their suction device with a view to support the critical care sector. The major aim of this device was to facilitate fluid removal and suction during the management provided with the help of ventilators.